Hormone therapy impairs endothelial function in postmenopausal women with type 2 diabetes mellitus treated with rosiglitazone. [electronic resource]
Producer: 20041007Description: 4615-9 p. digitalISSN:- 0021-972X
- Aged
- Blood Pressure
- Coronary Disease -- etiology
- Cross-Over Studies
- Diabetes Mellitus, Type 2 -- drug therapy
- Double-Blind Method
- Endothelium, Vascular -- drug effects
- Estradiol -- administration & dosage
- Female
- Hormone Replacement Therapy -- adverse effects
- Humans
- Lipids -- blood
- Middle Aged
- Postmenopause
- Progesterone -- administration & dosage
- Receptors, Cytoplasmic and Nuclear -- metabolism
- Rosiglitazone
- Thiazolidinediones -- therapeutic use
- Transcription Factors -- metabolism
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.